Company news

Rebus Hldgs Inc. news in 2015

Rebus Hldgs Inc.'s news releases, calls and decks from 2015, newest first.

View company

GenSpera Announces Private Placement of $2.5 Million

December 23, 2015

GenSpera to Present at ICV Manhattan Investor Conference

December 8, 2015

Mipsagargin Demonstrates Clinical Benefit in Subset of Glioblastoma Patients

November 20, 2015

GenSpera Provides Update on Clinical Development Programs

November 13, 2015

World-Renowned Neuro-Oncologist Santosh Kesari, MD, PhD Joins GenSpera’s Scientific Advisory Board

October 29, 2015

GenSpera to Present at the BIO Investor Forum

October 14, 2015

GenSpera Announces Encouraging Interim Phase II Data for Glioblastoma, Showcases Positive Future for Mipsagargin Across Multiple Types of Solid Tumors

September 9, 2015

GenSpera to Present at Rodman & Renshaw 17th Annual Global Investment Conference

August 24, 2015

GenSpera Provides 2nd Quarter Corporate Update

August 10, 2015

GenSpera Phase II Abstract Accepted for Presentation at the Society of Neuro-Oncology 20th Annual Scientific Meeting

July 28, 2015

U.S. Court of Appeals Enters Judgment in Favor of GenSpera

July 20, 2015

Patent Application for GenSpera Partner Phyton Biotech Is Published by World Intellectual Property Organization (WIPO)

July 15, 2015

U.S. Food and Drug Administration's Office of Orphan Products Development Issues Grant Supporting GenSperas Glioblastoma Study

June 17, 2015

Craig A. Dionne to Speak at BIO International 2015

June 15, 2015

KTLA TV's Health Smart Showcases GenSpera's Cancer Research

June 9, 2015

GenSpera's CEO Craig A. Dionne Interviewed on Sirius Radio

June 3, 2015

GenSpera's CEO Craig A. Dionne to Present H.C. Wainwright & Co.'s Panel Discussion during ASCO 2015

May 20, 2015

GenSpera Expands Phase II Glioblastoma Trial of Mipsagargin

May 13, 2015

GenSpera Provides Corporate Update

May 11, 2015

GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations

May 6, 2015

GenSpera Granted New Patent for Prodrugs Activated by Prostate Specific Antigen

April 28, 2015

GenSpera Launches National Investor Relations Program

March 30, 2015

GenSpera Presents at BIO Asia International Conference

March 17, 2015